Log in to save to my catalogue

Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences...

Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4d7fc8dcbfb540b2928a445f125243c0

Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

About this item

Full title

Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Publisher

England: BioMed Central Ltd

Journal title

Molecular neurodegeneration, 2022-12, Vol.17 (1), p.85-14, Article 85

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Advances in ultrasensitive detection of phosphorylated tau (p-tau) in plasma has enabled the use of blood tests to measure Alzheimer's disease (AD) biomarker changes. Examination of postmortem brains of participants with antemortem plasma p-tau levels remains critical to understanding comorbid and AD-specific contribution to these biomarker changes...

Alternative Titles

Full title

Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4d7fc8dcbfb540b2928a445f125243c0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4d7fc8dcbfb540b2928a445f125243c0

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-022-00578-0

How to access this item